The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.

We found increased rates of nonliver malignancies in HBsAg-positive participants, the increases being most pronounced in those who were HBV DNA positive and for NHL. If confirmed, these results may have implications for increased cancer screening in HIV-positive subjects with chronic HBV infection.